![](/img/cover-not-exists.png)
A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517
Kirschbaum, Mark H., Goldman, Bryan H., Zain, Jasmine M., Cook, James R., Rimsza, Lisa M., Forman, Stephen J., Fisher, Richard I.Volume:
53
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2011.608448
Date:
February, 2012
File:
PDF, 200 KB
english, 2012